Old Dominion Freight Line Inc vs Organon & Co. Common Stock — how do they compare? Old Dominion Freight Line Inc trades at $184.79 (market cap $37.98B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Old Dominion Freight Line Inc is far larger — about 10.5× Organon & Co. Common Stock's market cap, and Old Dominion Freight Line Inc pays the higher dividend (0.63%). Which is the better fit depends on your goals — on Pluang, investors hold Old Dominion Freight Line Inc for 77 Days and Organon & Co. Common Stock for 0 Days on average.
| ODFL | OGN | |
|---|---|---|
Market Cap | $37.98B | $3.62B |
Volume | 1,713,056 | 2,892,999 |
Sector | Industrials | Health |
52-Week High | $248.73 | $13.81 |
52-Week Low | $126.29 | $5.70 |
Typical Hold Time | 77 Days | 0 Days |
Enterprise Value | $37.72B | $11.04B |
Dividend Yield | 0.63% | 0.58% |
Signals from Pluang's Aura AI — not financial advice
Old Dominion Freight Line (ODFL) trades at $184.37, up 1.35% today, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.68 exceeding the $1.54 estimate. Revenue for 2025 was $5.50B, with a net income margin of 19.44%. A 4.9% general rate increase effective October 5, 2026, aims to offset rising costs and support network investments.
ODFL presents a mixed outlook: robust profitability and analyst consensus target of $230.93 suggest upside, but high valuation multiples (P/E 35.23) and bearish technicals indicate near-term pressure. Key risks include freight demand volatility and competitive pressures, while institutional buying and earnings momentum support long-term growth potential.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →